Delhi high court has already given a stay order on the ban of fixed dose combination drug when at least 14 pharma giants filed a petition against the notification. Many questions were raised from pharma side as well from different other section of healthcare industry –What is the rationale for banning the drugs that are doing good in the market for long? Who approved those formulations earlier? Is not it a hasty and overnight decision? Who are behind this ban?
Finally, the man behind this ban speaks out. The ban of 344 fixed dose combination drugs by the government that shook the healthcare industry recently, is being highly questioned by drug makers. Companies have already earned an injunction and many are about to knock the door legislation. The question raised from Pharma sides are: Some of the banned formulations have a well-established efficacy and safety profile in India for more…
